Recent confusion and ongoing actions related to the FDA’s Inactive Ingredient Database (IID) - What should be included in the ANDA?
David R. Schoneker
Global Regulatory Affairs, Colorcon, Harleysville, PA
988-5134-1-PB.pdf
Adobe Acrobat Document
127.9 KB